Recent findings on the use of ß-adrenergic blockers in patients with congestive heart failure (CHF) are reviewed. CHF is a progressive, debilitating disease that afflicts 4.6 million patients in the ...

The addition of β-adrenergic antagonists to the treatment regimen for heart failure has validated the neurohormonal hypothesis and provided much-improved outcomes. This benefit had been in question ...

News-Medical spoke to researchers Dr. Nirmal Robinson, Dr. Vincenzo Desiderio, and Dr. Antonio Barbieri about their latest research into beta-blockers, and how they could potentially be used to treat ...

Nearly half of all adults in the U.S. have high blood pressure, or hypertension, according to the CDC. One of the most common ...

At the American Society of Clinical Oncology (ASCO) annual meeting, researchers reported on a trial in progress that hopes to prove that blocking the effects of adrenergic stress with propranolol, a ...

Please provide your email address to receive an email when new articles are posted on . Taking beta blockers may raise mortality risk for HSCT recipients due to suppression of signals from nerves that ...

Reductions in violence are seen in individuals using Beta adrenergic-blocking agents (Beta-blockers) compared with periods that they are not taking the medication, a new study finds. If the findings ...

Cleveland Clinic researchers have made a significant discovery about how the gut microbiome interacts with cells to cause cardiovascular disease. The Nature Communications study found ...